Search Results
BPI22-022: Real World Adherence to Biomarker Testing Guidelines That Inform First-Line Treatment Decisions for Patients Newly Diagnosed With Metastatic Non-Small Cell Lung Cancer in the Community Setting
Amy M. Pasmann, William E. Nibley, Scott D. Goldfarb, Veena Shetty, Jon M. Apple, and Anne Shah
The Microbiome Colorectal Cancer Puzzle: Initiator, Propagator, and Avenue for Treatment and Research
Reece J. Knippel and Cynthia L. Sears
bacteria produce toxins, such as Bacteroides fragilis toxin and colibactin, that alter CEC signaling and/or damage CEC DNA, resulting in mutations and/or cytotoxicity that further alter host and microbial community function. (C) This multifactorial
SupportScreen: A Model for Improving Patient Outcomes
Matthew Loscalzo, Karen Clark, Jeff Dillehunt, Redmond Rinehart, Rex Strowbridge, and Daniel Smith
to be a time-consuming and daunting task for physicians when they have increasingly less time to spend with patients. This is true in both large academic cancer centers and small community practices. Several studies show the financial
Nationwide Trends and Determinants of Germline BRCA1/2 Testing in Patients With Breast and Ovarian Cancer
Kelsey S. Lau-Min, Anne Marie McCarthy, Katherine L. Nathanson, and Susan M. Domchek
unstructured data, curated via technology-enabled abstraction. 13 The database included data from approximately 280 community and academic cancer clinics (∼800 sites of care) during the study period. Demographic variables for patients in the Flatiron Health
Apoyo con Cariño: Strategies to Promote Recruiting, Enrolling, and Retaining Latinos in a Cancer Clinical Trial
Stacy M. Fischer, Danielle M. Kline, Sung-Joon Min, Sonia Okuyama, and Regina M. Fink
the strategies we implemented to achieve our enrollment goals and engage an underrepresented population in a CCT. Methods Formative Work We developed our study methods and intervention content using community participatory action methods. We
HSR19-100: CancerSupportSource®-15: Development and Evaluation of a Short Form of a Distress Screening Program for Cancer Survivors
Shauna McManus, Alexandra K. Zaleta, Melissa F. Miller, Joanne S. Buzaglo, Julie S. Olson, Sara Goldberger, and Kevin Stein
Background: CancerSupportSource (CSS) is a 25-item distress screening tool implemented at community-based cancer support organizations and hospitals nationwide. CSS assesses distress over 5 domains: (1) emotional concerns (including depression and
Plenary Session—The Patient Journey: Equity of Cancer Care
Presented by: Thomas A. Farrington, Liz Margolies, Shonta Chambers, Maria D. Garcia-Jimenez, and Alyssa A. Schatz
Moderated by: Carmen E. Guerra
to Mr. Farrington, the patient community understands that early detection, screening, and prevention are high priorities that need to be addressed to achieve equity in cancer care, but disparities during the treatment phase are another concern
Prevention and Early Treatment of Opportunistic Viral Infections in Patients With Leukemia and Allogeneic Stem Cell Transplantation Recipients
Michael Angarone and Michael G. Ison
analysis . Biol Blood Marrow Transplant 2004 ; 10 : 58 – 64 . 101. Nichols WG Gooley T Boeckh M . Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred
Reaching Populations to Address Disparities in Cancer Care Delivery: Results From a Six-Site Initiative
Noël Arring, Christopher R. Friese, Bidisha Ghosh, Marita Titler, Heidi Hamann, Sanja Percac-Lima, Adrian Sandra Dobs, Michelle J. Naughton, Pooja Mishra, Melissa A. Simon, Bingxin Chen, Electra D. Paskett, Robert J. Ploutz-Snyder, Martha Quinn, and Debra L. Barton
overcoming health inequities. The Alliance members used 4 key evidence-based strategies to improve enrollment of people who have been underserved by quality cancer care in their programs: nurse and lay navigators, community-based participatory approaches
NCCN Patient Advocacy Summit: Delivering Value for Patients Across the Oncology Ecosystem
Terrell Johnson, Lindsey A.M. Bandini, Darryl Mitteldorf, Elizabeth Franklin, Justin E. Bekelman, and Robert W. Carlson
to cancer care that is multispecialty, multisite, and has multiple therapeutic options. In the midst of this changing landscape, members of the patient community are voicing concerns about the lack of inclusion and patient-centricity in the cancer
